Neos, Teva settle litigation over ADHD drug By: Philadelphia Business Journal via Business Journals December 26, 2018 at 10:48 AM EST The settlement includes a licensing deal that will allow Teva to market a generic version of Cotempla beginning mid-2026. Read More >>
